Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Goodwill & Intangibles (2021 - 2025)

InMed Pharmaceuticals' Goodwill & Intangibles history spans 5 years, with the latest figure at $1.5 million for Q4 2025.

  • For Q4 2025, Goodwill & Intangibles fell 9.56% year-over-year to $1.5 million; the TTM value through Dec 2025 reached $1.5 million, down 9.56%, while the annual FY2025 figure was $1.6 million, 44.64% down from the prior year.
  • Goodwill & Intangibles reached $1.5 million in Q4 2025 per INM's latest filing, down from $2.9 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $4.7 million in Q1 2022 to a low of $1.0 million in Q3 2021.
  • Average Goodwill & Intangibles over 5 years is $2.4 million, with a median of $2.0 million recorded in 2022.
  • Peak YoY movement for Goodwill & Intangibles: tumbled 57.65% in 2023, then surged 112.51% in 2024.
  • A 5-year view of Goodwill & Intangibles shows it stood at $4.4 million in 2021, then tumbled by 54.18% to $2.0 million in 2022, then skyrocketed by 44.43% to $2.9 million in 2023, then tumbled by 41.89% to $1.7 million in 2024, then fell by 9.56% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for INM's Goodwill & Intangibles are $1.5 million (Q4 2025), $2.9 million (Q3 2025), and $1.6 million (Q2 2025).